1,050.00p-10.00 (-0.94%)20 May 2022, 18:01
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Ergomed PLC Fundamentals

Company NameErgomed PLCLast Updated2022-05-20
Shares in Issue49.520 mMarket Cap£519.96 m
PE Ratio41.84Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£0.25EPS Growth (%)0.56
PEG0DPS Growth (%)0
Debt Ratio0.0253Debt Equity Ratio0.0213
Asset Equity Ratio1.5763Cash Equity Ratio0.4647
Quick Ratio1.5914Current Ratio1.71
Price To Book Value7.7340ROCE0

Ergomed PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Ergomed PLC Company Financials

Tangible Assets£4.63 m£6.46 m£6.28 m
Intangible Assets£31.56 m£34.22 m£16.14 m
Total Fixed Assets£45.65 m£45.58 m£25.03 m
Debtors£25.06 m£25.87 m£16.23 m
Cash & Equivalents£31.24 m£18.99 m£14.26 m
Other Assets£9.46 m£4.90 m£2.62 m
Total Assets£105.99 m£92.35 m£57.03 m
Creditors within 1 year£35.38 m£33.61 m£15.86 m
Creditors after 1 year£3.37 m£5.87 m£4.35 m
Other Liabilities000
Total Liabilities£38.75 m£39.48 m£20.21 m
Net assets£67.24 m£52.87 m£36.82 m
Called up share capital£493,000.00£489,000.00£473,000.00
Share Premium£545,000.00£3,000.00£25.79 m
Profit / Loss£14.26 m£12.63 m£4.99 m
Other Equity£67.24 m£52.87 m£36.82 m
Preference & Minorities000
Total Capital Employed£67.24 m£52.87 m£36.82 m
Debt Ratio£0.02£0.06£0.09
Assets / Equity1.57631.57631.5763
Cash / Equity0.46470.46470.4647
Cash Flow202120202019
Cash from operating activities£18.68 m£18.05 m£11.79 m
Cashflow before financing£16.57 m£17.57 m£11.54 m
Increase in Cash£12.42 m£4.79 m£8.71 m
Turnover£118.58 m£86.39 m£68.25 m
Cost of sales£70.22 m£46.74 m£38.73 m
Gross Profit£48.36 m£39.65 m£29.52 m
Operating Profit£14.62 m£13.53 m£5.52 m
Pre-Tax profit£14.26 m£12.63 m£4.99 m

Ergomed PLC Company Background

ActivitiesErgomed PLC is engaged in the healthcare sector. Its business involves the provision of drug development services to the pharmaceutical industry. The company operates through two segments: Clinical Research Outsourcing and Pharmacovigilance. It provides clinical development services to clients ranging from top 10 pharmaceutical companies to small and mid-sized drug development companies. The PV segment has expertise in the field of pharmacovigilance and provides medical information services.
Latest Interim Date28 Sep 2021
Latest Fiscal Year End Date29 Mar 2022

Ergomed PLC Directors

2019-06-18Mr. Stuart Robert JacksonExecutive Director,Chief Financial Officer
2022-05-13Mr. Rolf Kristian Soderstrom Non-Executive Director,Senior Independent Director
2022-05-13Mr. Ian Roy Johnson Non-Executive Director
2022-05-13Mr. Richard Timothy BarfieldExecutive Director,Chief Financial Officer
2018-05-21Mr. Rolf StahelNon-Executive Director,Chairman
2018-05-22Mr. Neil Robert ClarkExecutive Director,Chief Executive Officer, PrimeVigilance
2019-05-17Mr. Stephen Anthony Stamp Executive Director,Chief Executive Officer
2019-09-25Mr. Peter Lutz GeorgeNon-Executive Director
2022-05-13Dr. Miroslav ReljanovicExecutive Director,Chairman
2019-03-11Mr. Christopher CollinsNon-Executive Director
2021-05-14Mr. Andrew MackieExecutive Director,Chief Business Officer
2018-05-22Mr. Sanja Juric Company Secretary
2019-09-18Dr. Jan PetracekExecutive Director,Chief Operating Officer
2020-05-15Dr. James Douglas Esinhart Non-Executive Director
2020-09-22Mr. Lewis Cameron Executive Director,Chief Operating Officer

Ergomed PLC Contact Details

Company NameErgomed PLC
Address1 Occam Court, The Surrey Research Park, Guildford, GU2 7HJ
Telephone+44 1483503205

Ergomed PLC Advisors

StockbrokerN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
Financial PR AdviserMC Services AG
Phone+49 892102280
Fax+49 8921022888
Nominated AdviserNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
StockbrokerNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
RegistrarShare Registrars Limited
Phone+44 1252821390
Fax+44 1252719232
AuditorDeloitte LLP
Phone+44 1223460222
Fax+44 1223350839
SolicitorCovington & Burling LLP
Phone+44 2070672000
Fax +44 2070672222